A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C

被引：0
|
作者：
Sampson, M. [1 ]
Meeusen, J. W. [2 ]
Donato, L. J. [2 ]
Jaffe, A. S. [2 ]
Remaley, A. T. [3 ]
机构：
[1] NIH, DLM, CC, Bethesda, MD USA
[2] Mayo Clin, Rochester, MN USA
[3] NIH, NHLBI, Bethesda, MD USA
来源：
CLINICAL CHEMISTRY | 2024年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
A-231
引用
收藏
页码：I88 / I88
页数：1
相关论文
共 50 条
  • [21] LDL-C: Is lower better?
    不详
    CANADIAN JOURNAL OF CARDIOLOGY, 1999, 15 (12) : 1384 - 1385
  • [22] Comparability of calculated LDL-C with directly measured LDL-C in selected paediatric and adult cohorts
    Steyn, Nicolene
    Rossouw, H. Muller
    Pillay, Tahir S.
    Martins, Janine
    CLINICA CHIMICA ACTA, 2022, 537 : 158 - 166
  • [23] Very low LDL-C levels on alirocumab do not increase AEs
    Reactions Weekly, 2017, 1638 (1) : 12 - 12
  • [24] Achieving LDL-C target levels: The role of statins
    Lablanche, JM
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 16 (04) : 285 - 295
  • [25] Extended-Release Niacin Reduces LDL-C Particle Number Even In The Absence Of Changes In Total LDL-C Levels
    Jafri, Haseeb
    Kuvin, Jeffrey T.
    Alsheikh-Ali, Alawi A.
    Mooney, Paula
    Kimmelstiel, Carey D.
    Karas, Richard H.
    CIRCULATION, 2008, 118 (18) : S1150 - S1150
  • [26] REDUCTION OF LDL-C LEVELS IS MOST IMPORTANT - PATIENT PREFERENCES FOR DRUG TREATMENT ADJUNCT TO LDL-C APHERESIS IN SEVERE HYPERCHOLESTEROLEMIA
    Muehlbacher, A. C.
    Sadler, A.
    Dippel, F.
    Juhnke, C.
    VALUE IN HEALTH, 2017, 20 (09) : A622 - A623
  • [27] Ldl-c to non-hdl-c ratio method: a simple way to determine bias for ldl-c methods on hypertriglyceridemic samples
    Gcingca, T. A.
    Sampson, M.
    Meeusen, J. W.
    Donato, L. J.
    Jaffe, A. S.
    Remaley, A. T.
    CLINICAL CHEMISTRY, 2024, 70
  • [28] THE RELATIONS AMONG SMALL AND DENSE LDL-C, TG, LDL-C, NON-HDL-C AND BCL SCORE
    Omi, T.
    ATHEROSCLEROSIS, 2020, 315 : E157 - E157
  • [29] Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia
    Zubiran, Rafael
    Vargas-Vazquez, Arsenio
    Olvera, Fabiola Del Razo
    Cruz-Bautista, Ivette
    Martagon-Rosado, Alexandro
    Sampson, Maureen
    Remaley, Alan T.
    Aguilar-Salinas, Carlos A.
    ATHEROSCLEROSIS, 2023, 386
  • [30] The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia
    Luo, Zhu
    Huang, Zhijun
    Sun, Feng
    Guo, Fang
    Wang, Yingying
    Kao, Sheena
    Yang, Guoping
    Huang, Jie
    Li, Jiaxin
    Zhao, Sylvia
    He, YanLing
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (03) : 392 - 400
12345